Related Experiment Videos
New concepts in bacterial vaginosis
1State University of New York, Buffalo School of Medicine and Biomedical Sciences.
American Family Physician
|October 1, 1991
Summary
Bacterial vaginosis (BV) is a common vaginal infection linked to an overgrowth of anaerobic bacteria and reduced lactobacilli. Diagnosis involves specific clinical signs, and oral metronidazole is the primary treatment, with clindamycin as an alternative.
Area of Science:
- Gynecology
- Microbiology
- Infectious Diseases
Background:
- Bacterial vaginosis (BV) is a prevalent polymicrobial vaginal infection.
- It is characterized by an imbalance in vaginal flora, specifically an increase in anaerobic bacteria and a decrease in protective lactobacilli.
Purpose of the Study:
- To outline the diagnostic criteria for bacterial vaginosis.
- To identify the recommended pharmacological treatments for bacterial vaginosis.
Main Methods:
- Diagnosis relies on identifying at least three of five key clinical findings.
- Findings include characteristic vaginal discharge, amine odor upon potassium hydroxide addition, presence of clue cells, absence of lactobacilli, and elevated vaginal pH (>4.7).
Main Results:
- The presence of three or more diagnostic criteria confirms bacterial vaginosis.
- Oral metronidazole is established as the first-line treatment.
- Clindamycin is presented as a viable alternative therapeutic option.
Conclusions:
- Accurate diagnosis of bacterial vaginosis is achievable through established clinical criteria.
- Effective treatment options, including oral metronidazole and clindamycin, are available for managing bacterial vaginosis.